The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome
NCT00664742
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
614
Enrollment
INDUSTRY
Sponsor class
Conditions
Metabolic Syndrome
Interventions
DRUG:
Fluvastatin XL®
Sponsor
Novartis